LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Stock List・Moderna Inc

Moderna Inc

Closed

Sector Healthcare

72.88 -0.48

Buy Sell

Overview

Share price change

24h

Current

Min

72.16

Max

73.08

Key metrics
By Trading Economics
Income	-104M -1.3B
Sales	-167B 241M
P/E Sector Avg	35.86 103.001
EPS	-3.33
Profit margin	-530.705
Employees	5,600
EBITDA	-109M -1.2B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+76.62 upside

Dividends
By Dow Jones
Next Earnings	31 Oct 2024

Market Stats
By TradingEconomics
Market Cap	-65M 30B
Previous open	73.36
Previous close	72.88

News Sentiment

By Acuity

31%

69%

58 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

71.62 / 77.46 Support & Resistance

Moderna Inc Chart

Related News

13 Dec 2023, 13:16 UTC

Major Market Movers

Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer

14 Oct 2023, 00:02 UTC

Hot Stocks

Stocks to Watch: Pfizer, Moderna, Lululemon Athletica

11 Sept 2023, 11:39 UTC

Major Market Movers

Immatics Shares Rise Premarket on Collaboration With Moderna

6 Sept 2024, 11:00 UTC

Top News

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3 Sept 2024, 04:00 UTC

Top News

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

23 Aug 2024, 18:38 UTC

Top News

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

2 Aug 2024, 21:29 UTC

Top News

The Score: CrowdStrike, Apple, Intel and More Stocks That Defined the Week -- WSJ

1 Aug 2024, 10:30 UTC

Top News

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

3 Jul 2024, 14:18 UTC

Acquisitions, Mergers, Takeovers

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

30 May 2024, 19:45 UTC

Top News

Bird Flu Confirmed in Third Farmworker. It's the First Case With Respiratory Symptoms. -- Barrons.com

29 May 2024, 15:56 UTC

Earnings

Acquisitions, Mergers, Takeovers

The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. -- Barrons.com

10 May 2024, 20:11 UTC

Earnings

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 May 2024, 14:49 UTC

Earnings

Hot Stocks

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

2 May 2024, 13:46 UTC

Earnings

Hot Stocks

Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton -- WSJ

2 May 2024, 10:31 UTC

Earnings

Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout? -- IBD

2 May 2024, 09:08 UTC

Hot Stocks

Stocks to Watch Thursday: Shell, Novo Nordisk, Apple -- WSJ

28 Feb 2024, 14:14 UTC

Earnings

Novavax Stock Sinks as Revenue Misses Estimates in 'Transition Year' -- Barrons.com

22 Feb 2024, 16:00 UTC

Top News

Moderna Is Pivoting From Covid and the Results Are on Their Way -- Heard on the Street -- WSJ

22 Feb 2024, 12:40 UTC

Earnings

Moderna Stock Jumps on Surprise Profit After Earnings Beat. What to Expect in 2024. -- Barrons.com

2 Nov 2023, 16:53 UTC

Earnings

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat -- IBD

2 Nov 2023, 08:58 UTC

Earnings

These Stocks Are Moving the Most Today: Qualcomm, PayPal, SolarEdge, Roku, DoorDash, E.l.f. Beauty, and More -- Barrons.com

31 Oct 2023, 16:35 UTC

Top News

Earnings

Nevermind Covid, Investors Want a Pfizer Obesity Pill -- Heard on the Street -- WSJ

17 Oct 2023, 10:00 UTC

Top News

Pfizer Looks for a Covid Bottom -- Heard on the Street -- WSJ

26 Sept 2023, 09:30 UTC

Top News

The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out -- WSJ

13 Sept 2023, 12:00 UTC

Top News

Moderna Rises on Positive Results From Flu Vaccine, and Other Plans to Move Beyond Covid -- Barrons.com

12 Sept 2023, 13:00 UTC

Top News

CDC Advisers Weigh Covid-19 Booster Guidance as Latest Variants Spread -- WSJ

11 Sept 2023, 18:27 UTC

Top News

FDA Approves Newest Covid-19 Boosters -- Update

11 Sept 2023, 17:55 UTC

Top News

FDA Approves Newest Covid-19 Boosters -- WSJ

11 Sept 2023, 11:24 UTC

Major Market Movers

Immatics Shares Rise Premarket on Collaboration With Moderna >IMTX

Peer Comparison

Price change

Moderna Inc Forecast

Price Target

By TipRanks

76.62% upside

12 Months Forecast

Average 129.71 USD 76.62%

High 310 USD

Low 58 USD

Based on 19 Wall Street analysts offering 12 month price targets forModerna Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

19 ratings

Buy

Hold

Sell

Based on 19 analysts giving stock ratings to Moderna Inc - Dist in the past 3 months.

Technical Score

By Trading Central

71.62 / 77.46Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

58 / 365 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Moderna Inc

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.